Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial)

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2026

Primary Completion Date

March 1, 2029

Study Completion Date

March 1, 2030

Conditions
Neuropathic PainSleep QualityTranscranial Direct Current Stimulation
Interventions
DEVICE

tDCS

This group will receive single-phase direct current with an intensity of 2 mA up. Electrodes with a size of 35cm² (5 x 7 centimeters) will be used. Electrodes will be placed on the scalp, fixed with elastic bands, and immersed in 10 to 12 mL of saline solution.

DEVICE

sham intervention

The device displays will be identical across active and sham groups, and to ensure blinding, an active current will be applied for 30 seconds at the beginning and end of the sham stimulation to mimic the sensation of the current ramp experienced in active stimulation. Stimulations of less than 3 minutes of tDCS do not induce cortical excitability effects, according to Nitsche and Paulus (2000), being safely inactive for the expected results.

Trial Locations (1)

74423-120

Hospital da Polícia Militar de Goiás, Goiânia

All Listed Sponsors
collaborator

Hospital das Clínicas de São Paulo - SP

UNKNOWN

lead

Hospital da Polícia Militar de Goiás

NETWORK

NCT06994390 - Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial) | Biotech Hunter | Biotech Hunter